The frequency of anxiety and depression symptoms among U.S. adults increased after August 2020 and peaked during December 2020 and January 2021, mirroring the national weekly number of new COVID-19 cases, according to a study released yesterday by the Centers for Disease Control and Prevention. Average anxiety severity scores reported by adults to the U.S. Census Bureau Household Pulse Survey increased 13% from August to December 2020, then decreased 27% from December 2020 to June 2021, with similar increases and decreases in depression severity scores over the period, the study found. The authors said the findings, which precede the surge in COVID-19 cases from the delta variant, suggest that mental health services and resources “are critical during the COVID-19 pandemic, particularly among populations disproportionately affected by COVID-19.” 

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…